AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 31939849
Drug: 2 mg
RxNorm normalized name: iodine 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mg hydromorphone for spinal surgery
Trial: 31939849
Drug: 12 μg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 12 μg/kg fentanyl for cardiac surgery
Trial: 26584456
Drug: Topical Diclofenac
RxNorm normalized name: diclofenac Topical Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical Diclofenac (20 mg bis in die)
Trial: 22445438
Drug: Ketoconazole (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketoconazole (400 mg, days 8-14)
Trial: 22445438
Drug: Erythromycin (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erythromycin (500 mg three times daily, days 8-14)
Trial: 12763985
Drug: Oral ferrous
RxNorm normalized name: ferrous fumarate Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral ferrous sulphate (80 mg/day of elemental iron daily; n=75)
Trial: 1357070
Drug: Dexamethasone (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone (2 mg oral, every 6 hours for 48 hours) + Placebo + GHRH (100 micrograms i.v.)
Trial: 1357070
Drug: Placebo (oral,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (oral, every 6 hours for 48 hours) + Placebo + GHRH (100 micrograms i.v.)
Trial: 3899675
Drug: Citalopram 25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Citalopram 25 mg once daily
Trial: 3899675
Drug: Citalopram 50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Citalopram 50 mg once daily
Trial: 3899675
Drug: Citalopram (various
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Citalopram (various doses)
Trial: 28296349
Drug: α-glucosidase inhibitors
RxNorm normalized name: alpha glucosidase
FDA approved: no
EMA approved: no
PMDA approved: no
Description: α-glucosidase inhibitors (αGI)
Trial: 18458306
Drug: Primaquine, 30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Primaquine, 30 mg a day for 5 days
Trial: 18458306
Drug: Primaquine, 30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Primaquine, 30 mg a day for 7 days
Trial: 18458306
Drug: Primaquine, 30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Primaquine, 30 mg a day for 9 days
Trial: 18458306
Drug: Primaquine, 30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Primaquine, 30 mg a day for 11 days
Trial: 18458306
Drug: Primaquine, 30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Primaquine, 30 mg a day for 14 days
Trial: 18458306
Drug: Primaquine, 30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Primaquine, 30 mg twice a day for 7 days
Trial: 11253883
Drug: Intracameral pilocarpine
RxNorm normalized name: Pilocarpine
DrugBank: Pilocarpine (DB01085)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intracameral pilocarpine (0.13 mg/ml in BSS)
Trial: 31168046
Drug: Medical therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medical therapy for STEMI
Trial: 31168046
Drug: Medical therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medical therapy for AP
Trial: 22669229
Drug: Multimodal hand
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multimodal hand hygiene improvement strategy (training sessions, hydroalcoholic solutions, reminder posters)
Trial: 15954910
Drug: Long-acting somatostatin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Long-acting somatostatin (octreotide-LAR, 40 mg intramuscularly every 28 days)
Trial: 12410487
Drug: Recombinant human
RxNorm normalized name: Recombinant human TNF
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Recombinant human growth hormone (GH) at a dose of 0.1 mg/kg/day
Trial: 11030804
Drug: Vitamin E
RxNorm normalized name: Vitamin E
DrugBank: Vitamin E (DB00163)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vitamin E supplementation (50 mg)
Trial: 11030804
Drug: Beta carotene
RxNorm normalized name: Beta Carotene
DrugBank: Beta carotene (DB06755)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beta carotene supplementation (20 mg)
Trial: 8835043
Drug: Amoxicillin (Trimox)
RxNorm normalized name: Amoxicillin
DrugBank: Amoxicillin (DB01060)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amoxicillin (Trimox)
Trial: 8835043
Drug: Amoxicillin (Amoxil)
RxNorm normalized name: Amoxicillin
DrugBank: Amoxicillin (DB01060)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amoxicillin (Amoxil)
Trial: 31953303
Drug: Tacrolimus (0.05
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tacrolimus (0.05 mg/kg twice daily)
Trial: 31953303
Drug: Prednisolone (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prednisolone (1 mg/kg daily up to 60 mg daily)
Trial: 28931411
Drug: Topiramate (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topiramate (100 mg per day as add-on therapy to antipsychotics)
Trial: 28931411
Drug: Placebo (treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (treatment as usual with antipsychotics)
Trial: 26167680
Drug: Individualized-protocol with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Individualized-protocol with adjusted injection rate based on patient weight and contrast medium concentration (280 mgI/kg)
Trial: 26167680
Drug: Conventional contrast
RxNorm normalized name: Contrased
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional contrast injection protocol with total injection volume of 80ml and constant injection rate of 5.5ml/s
Trial: 21519151
Drug: Control (ACE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (ACE inhibitor treatment without β-blockade)
Trial: 10714475
Drug: 10-day moxifloxacin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10-day moxifloxacin 400 mg once daily
Trial: 8299614
Drug: Vitamin C
RxNorm normalized name: Vitamin C
DrugBank: Sodium ascorbate (DB14482)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin C (400 mg)
Trial: 2153424
Drug: Placebo (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (400 mg)
Trial: 18801303
Drug: Rocuronium 0.15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rocuronium 0.15 mg/kg repeated doses
Trial: 9366716
Drug: Parenteral group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Parenteral group (n = 86)
Trial: 2737225
Drug: Alifedrine 50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alifedrine 50 mg
Trial: 17445351
Drug: Daily consumption
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily consumption of 1440 kJ serving of almonds for 10 weeks
Trial: 17445351
Drug: Daily consumption
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily consumption of almonds
Trial: 7672677
Drug: Omeprazole 20
RxNorm normalized name: omeprazole 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole 20 mg twice daily plus amoxicillin 1 g twice daily
Trial: 7672677
Drug: Omeprazole 40
RxNorm normalized name: omeprazole 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole 40 mg twice daily plus amoxicillin 1 g twice daily
Trial: 17037995
Drug: Proton pump
RxNorm normalized name: Proton pump inhibitor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Proton pump inhibitors (PPIs); duration 8-16 weeks.
Trial: 12632615
Drug: Colloid preloading
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Colloid preloading (6% hydroxyethyl starch; HES) at 8 ml.kg‐1 before spinal anesthesia
Trial: 11013810
Drug: Perioperative antibiotic
RxNorm normalized name: ENSURE SURGERY PERIOPERATIVE KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Perioperative antibiotic prophylaxis (PAP) as per the quality standard developed in 1994.
Trial: 1678643
Drug: 3 g
RxNorm normalized name: Molds 3 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 g of oral calcium supplementation/day for three months postoperatively
Trial: 25294589
Drug: Enoxaparin 2000
RxNorm normalized name: enoxaparin
DrugBank: Enoxaparin (DB01225)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enoxaparin 2000 IU subcutaneously twice daily
Trial: 20353031
Drug: Zishen Shengxue
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zishen Shengxue Recipe (ZSR) combined with subcutaneous injection of erythropoiesis stimulating factor (rHuEpo)
Trial: 12153828
Drug: Antidepressant medication
RxNorm normalized name: ANTIDEPRESSANTS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antidepressant medication (tricyclic antidepressants and phenelzine)
Trial: 12153828
Drug: Psychotherapy (primarily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Psychotherapy (primarily cognitive behavior and interpersonal therapies)
Trial: 8537416
Drug: No pressure
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No pressure garment therapy
Trial: 2197046
Drug: TP‐1 (Serono;
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TP‐1 (Serono; 1 mg/kg body weight) administered by daily i.m. injections for the first 14 days followed by two injections/week for 6 further weeks
Trial: 6363099
Drug: Regular +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regular + NPH‐Biosynthetic human insulin
Trial: 20939917
Drug: Brief cognitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Brief cognitive behavioral therapy (8 sessions)
Trial: 7038945
Drug: 4.5 milligram
RxNorm normalized name: Product containing precisely ganciclovir 4.5 milligram/1 each prolonged-release ocular implant (clinical drug)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4.5 milligram epidurally administered morphine sulfate
Trial: 7038945
Drug: 2 milligram
RxNorm normalized name: Clonazepam 2 MILLIGRAM In 1 TABLET ORAL TABLET
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 milligram epidurally injected morphine sulfate
Trial: 17445637
Drug: EMLA cream
RxNorm normalized name: LIDOCAINE 25 mg in 1 g / PRILOCAINE 25 mg in 1 g TOPICAL CREAM [Emla Cream]
DrugBank: Prilocaine (DB00750)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: EMLA cream (10 g)
Trial: 17445637
Drug: DMSO with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DMSO with lidocaine (10 g of 40% DMSO)
Trial: 15127090
Drug: Vitamin C
RxNorm normalized name: Vitamin C
DrugBank: Sodium ascorbate (DB14482)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin C (250 mg twice daily)
Trial: 2769581
Drug: Acetylsalicylic acid
RxNorm normalized name: ACETYLSALICYLIC ACID
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Acetylsalicylic acid (ASA) mean daily intake of 1.29 grams
Trial: 2769581
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (20 healthy persons similar in age, taking no medication)
Trial: 30101
Drug: Naloxone (4.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naloxone (4.0 mg intravenous injection)
Trial: 2417477
Drug: Theophylline (oral,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Theophylline (oral, 8 to 22 micrograms/ml serum concentration)
Trial: 22873530
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg tofacitinib twice daily
Trial: 22873530
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg tofacitinib twice daily
Trial: 22873531
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg adalimumab once every 2 weeks
Trial: 18583219
Drug: Group 3
RxNorm normalized name: Chlamydophila psittaci biogroup 3 Ab
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group 3 (1 microg/mL naloxone and 1 mg/mL morphine)
Trial: 18583219
Drug: Group 1
RxNorm normalized name: Chlamydophila psittaci biogroup 1 Ab
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group 1 (0 microg/mL naloxone and 1 mg/mL morphine)
Trial: 9077048
Drug: Hypnotic techniques
RxNorm normalized name: Synotic
DrugBank: Fluocinolone acetonide (DB00591)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hypnotic techniques (audiotape with relaxation induction and posthypnotic suggestions)
Trial: 9077048
Drug: No hypnotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No hypnotic techniques (control group)
Trial: 22143258
Drug: Progestin-only contraceptive
RxNorm normalized name: VCF Contraceptive
DrugBank: Nonoxynol-9 (DB06804)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Progestin-only contraceptive pills
Trial: 22143258
Drug: Combined hormonal
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Combined hormonal contraceptive pills
Trial: 22143258
Drug: Progestin-only and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Progestin-only and Combined hormonal contraceptive pills
Trial: 20464321
Drug: Subgroup A
RxNorm normalized name: RSV subgroup A stabilized prefusion F protein
DrugBank: Recombinant stabilized RSV A prefusion F antigen (DB18713)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subgroup A - F applied to enamel without an intermediate bonding agent layer
Trial: 18433918
Drug: Individualized treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Individualized treatment after 6 weeks of pegylated interferon‐alpha2a/ribavirin therapy
Trial: 18433918
Drug: Standard treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard treatment after 6 weeks of pegylated interferon‐alpha2a/ribavirin therapy
Trial: 15755826
Drug: Dietary counseling
RxNorm normalized name: sodium phosphate, monobasic
DrugBank: Sodium phosphate, monobasic (DB09449)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dietary counseling (and placebo capsules)
Trial: 15755826
Drug: Control (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (no dietary counseling and placebo capsules)
Trial: 14650955
Drug: 5‐fluorouracil (5‐FU)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5‐fluorouracil (5‐FU) plus leucovorin (LV) therapy for 6 months after curative resection of Dukes' C CRC
Trial: 14650955
Drug: Oral combination
RxNorm normalized name: clozapine ORAL COMBINATION PACKAGE (EA)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral combination of UFT and LV
Trial: 14650955
Drug: Intrahepatic arterial
RxNorm normalized name: Echinacea, aerial parts
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intrahepatic arterial infusion (IHA) therapy
Trial: 14650955
Drug: CPT‐11 as
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CPT‐11 as second-line therapy
Trial: 2005224
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of tetracycline-containing fibers and scaling
Trial: 6856646
Drug: Cocaine (16
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cocaine (16 mg, 32 mg, 48 mg)
Trial: 28301859
Drug: Social learning
RxNorm normalized name: Noxzema Clean
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Social learning and cognitive behavioral therapy in-person (SLCBT)
Trial: 28301859
Drug: Social learning
RxNorm normalized name: Noxzema Clean
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Social learning and cognitive behavioral therapy (remote condition only)
Trial: 23033237
Drug: Closed-loop therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Closed-loop therapy
Trial: 27532830
Drug: Control therapy
RxNorm normalized name: Benzoyl Peroxide;Salicylic Acid;Vitamin E 8%; 2%; 5% Topical application Kit [INOVA 8/2 ACNE CONTROL THERAPY]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control therapy (sensor-augmented pump therapy)
Trial: 27532830
Drug: Closed-loop therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Closed-loop therapy and Control therapy
Trial: 21979301
Drug: Prulifloxacin (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prulifloxacin (600 mg daily for 14 days) + FERTIMEV (1 vial daily for 6 months)
Trial: 8239223
Drug: Zileuton 2.4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zileuton 2.4 g/d
Trial: 8239223
Drug: Zileuton 1.6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zileuton 1.6 g/d
Trial: 25108907
Drug: HTO with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HTO with platelet-rich plasma (PRP) injection only (n = 23)
Trial: 25108907
Drug: HTO with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HTO with MSC therapy and PRP injection (n = 21)
Trial: 23441529
Drug: Methoxy polyethylene
RxNorm normalized name: Methoxy polyethylene glycol-epoetin beta
DrugBank: Methoxy polyethylene glycol-epoetin beta (DB09107)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Methoxy polyethylene glycol-epoetin beta (CERA) at alternative dose (113.08 mcg/month)
Trial: 12150309
Drug: Adjusted-dose warfarin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjusted-dose warfarin
Trial: 19202954
Drug: Enoxaparin once
RxNorm normalized name: enoxaparin
DrugBank: Enoxaparin (DB01225)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enoxaparin once daily
Trial: 15926135
Drug: Pregabalin at
RxNorm normalized name: Pregabalin
DrugBank: Pregabalin (DB00230)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Pregabalin at doses of 150 mg to 600 mg per day
Trial: 9861552
Drug: Methylphenidate (5.0-30.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylphenidate (5.0-30.0 mg)
Trial: 9861552
Drug: d-Amphetamine (2.5-20.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: d-Amphetamine (2.5-20.0 mg)
Trial: 27463
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg mepindolol
Trial: 27463
Drug: 15 mg
RxNorm normalized name: papain 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mg pindolol
Trial: 29284465
Drug: Acupuncture treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture treatment (3 times per week)
Trial: 29284465
Drug: Donepezil hydrochloride
RxNorm normalized name: Donepezil Hydrochloride
DrugBank: Donepezil (DB00843)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Donepezil hydrochloride (5 mg/day for first 4 weeks, then 10 mg/day thereafter)
Trial: 25544195
Drug: Hypericum 900-1500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hypericum 900-1500 mg/day
Trial: 7963447
Drug: Sertraline 50-100
RxNorm normalized name: sertraline 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sertraline 50-100 mg/day
Trial: 21307717
Drug: Dexamethasone 0.15
RxNorm normalized name: dexamethasone 0.15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone 0.15 mg/kg every 6 hours for 4 days
Trial: 11728676
Drug: Sildenafil citrate
RxNorm normalized name: Sildenafil Citrate
DrugBank: Sildenafil (DB00203)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sildenafil citrate (Viagra) 50 mg for 2 weeks, increased to 100 mg if needed; duration of treatment was 12 weeks.
Trial: 3497379
Drug: Orally administered
RxNorm normalized name: no vaccine administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Orally administered amoxicillin
Trial: 29216937
Drug: PPI group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PPI group (PPI < 1.4 for diagnosis, PPI > 2 for treatment)
Trial: 25363415
Drug: Tarafenacin 0.4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tarafenacin 0.4 mg
Trial: 25363415
Drug: Tarafenacin 0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tarafenacin 0.2 mg
Trial: 17845648
Drug: 2% lidocaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2% lidocaine (40 ml)
Trial: 17845648
Drug: 4% lidocaine
RxNorm normalized name: Lidocaine 344 mg TOPICAL PATCH [Pain Relief 4% Lidocaine]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4% lidocaine (40 ml)
Trial: 7912539
Drug: BRL35135 8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BRL35135 8 mg
Trial: 2645808
Drug: 0.4 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.4 mg/kg midazolam with 0.015-0.02 mg/kg atropine (Group I)
Trial: 2645808
Drug: 0.5 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 mg/kg midazolam with 0.015-0.02 mg/kg atropine (Group II)
Trial: 329858
Drug: Bromocriptine (2-5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bromocriptine (2-5 mg twice daily)
Trial: 30548573
Drug: Gamma-hydroxybutyric acid
RxNorm normalized name: gamma-Hydroxybutyric acid
DrugBank: gamma-Hydroxybutyric acid (DB01440)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gamma-hydroxybutyric acid (GHB) administration
Trial: 21521895
Drug: 5 mL
RxNorm normalized name: WATER,INHL 5 ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mL deionized water
Trial: 18444872
Drug: CPG 7909
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CPG 7909 adjuvant plus HBV vaccine
Trial: 18444872
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (HBV vaccine without CPG 7909)
Trial: 12574791
Drug: Liquorice consumption
RxNorm normalized name: Liquorice
DrugBank: Licorice (DB10675)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Liquorice consumption (100 g daily for 4 weeks, 150 mg glycyrrhetinic acid)
Trial: 10959541
Drug: d-amphetamine (AMP;
FDA approved: no
EMA approved: no
PMDA approved: no
Description: d-amphetamine (AMP; 10 and 20 mg)
Trial: 10959541
Drug: ethanol (EtOH;
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ethanol (EtOH; 0.2, 0.4, and 0.8 g/kg)
Trial: 9379784
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg oral buspirone
Trial: 9379784
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg oral buspirone
Trial: 26478208
Drug: escitalopram 10
RxNorm normalized name: escitalopram 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: escitalopram 10 mg/day + single-dose i.v. ketamine (0.5 mg/kg over 40 min)
Trial: 26478208
Drug: escitalopram 10
RxNorm normalized name: escitalopram 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: escitalopram 10 mg/day + placebo (0.9% i.v. saline)